Acquisition of MEDTOX Scientific by Laboratory Corporation of America Holdings (LabCorp) Clears Antitrust Approval

Published: Jul 13, 2012

ST. PAUL, Minn., July 13, 2012 (GLOBE NEWSWIRE) -- MEDTOX Scientific, Inc. (Nasdaq:MTOX) today announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, or HSR Act, applicable to the acquisition of MEDTOX by LabCorp.

Back to news